PR Newswire
NEW YORK, Oct. 22, 2018
NEW YORK, Oct. 22, 2018 /PRNewswire/ -- Chardan, a global investment bank, announced today that the firm acted as lead manager in the initial public offering of LogicBio Therapeutics, Inc. (NASDAQ: LOGC), raising aggregate gross proceeds of approximately $70.0 million. LogicBio began trading on the NASDAQ Capital Market on October 19, 2018.
Chardan has participated in advisory and capital raising transactions totaling more than $2 billion in 2018.
About Chardan
Chardan is an independent global investment bank specializing in healthcare, SPACs and emerging growth companies. Our range of services include capital raising, merger and acquisition advisory, strategic advisory, equity research, corporate access and institutional trading. Headquartered in New York City, Chardan is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: FINRA, SIPC, NASDAQ and the NYSE Arca, Inc.
Learn more about Chardan: www.chardan.com
Media Contact:
Emily Levine, Chardan
[email protected]
(646) 465-9018
Tom Rozycki, Prosek Partners
[email protected]
(646) 503-5657
View original content:http://www.prnewswire.com/news-releases/chardan-serves-as-lead-manager-for-logicbio-therapeutics-300735489.html
SOURCE Chardan Capital Markets, LLC
We use cookies to tailor your experience, measure site performance and present relevant offers and advertisements. By clicking ‘Accept’ or any content on this site, you agree that cookies can be placed on your browser. You can view our privacy policy to learn more.
If you would like to get more data, alerts and access to Real Vision videos, join us as an Insider Tracking Advantage Ultra member